O

OS Therapies Inc
AMEX:OSTX

Watchlist Manager
OS Therapies Inc
AMEX:OSTX
Watchlist
Price: 2.63 USD -1.87% Market Closed
Market Cap: 52.7m USD
Have any thoughts about
OS Therapies Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-18
Current
-19.3
Median
6
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-18
=
Enterprise Value
54.3m USD
/
Operating Cash Flow
-3m USD
All Countries
Close
Market Cap EV/OCF
US
OS Therapies Inc
AMEX:OSTX
54.1m USD -18
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 774.4
US
Abbvie Inc
NYSE:ABBV
300.2B USD 21.3
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 28.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.8B USD -127.5
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -475.5
AU
CSL Ltd
ASX:CSL
137.3B AUD 35.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.3B USD 19.1
US
Seagen Inc
F:SGT
39.3B EUR -74.4
NL
argenx SE
XBRU:ARGX
34.1B EUR -126.3
 
US
O
OS Therapies Inc
AMEX:OSTX
Average EV/OCF: 23.1
Negative Multiple: -18
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 774.4
US
Abbvie Inc
NYSE:ABBV
21.3
US
Amgen Inc
NASDAQ:AMGN
28.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -127.5
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.5
AU
CSL Ltd
ASX:CSL
35.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.3

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More